In their capacity as cancer promoters, TAMCs strongly facilitate angiogenesis through the liberation of a number of angiogenic molecules, e.g., TGF-β, EGF, fibroblast growth factor-2 (FGF-2), stem cell factor (SCF), heparin, histamine, MMP-9, and proteases [102]. The gene discussed is KITLG; the disease is cancer.